Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How would you approach additional workup and management of a patient with active Crohn’s disease, who has multiple lung and brain nodules, with lung pathology demonstrating necrotizing granulomatous inflammation and brain biopsy with granulomatous inflammation and medium-large vessel vasculitis?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

This is a great question and a challenging case. Further workup would depend on the clinical presentation and the risk factors of this particular patient, however, I will outline some broad considerations centered around questions I would consider in a similar case. Has Crohn's disease been definit...

What work-up do you recommend in patients with early-onset dementia?

3
1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

After a thorough history (especially drugs, alcohol and Family Hx) - would do: imaging study, TSH, B12 level and consider genetic labs and CSF for early onset dementia.

In what clinical situation do you use Botox in patients with increased salivation?

1 Answers

Mednet Member
Mednet Member
Neurology · Lucile Packard Childrens Hospital Stanford

Botulinum toxin injections are considered first-line pharmacologic management for sialorrhea due to their safety and efficacy with appropriate patient selection. It can be considered for patients who have increased aspiration risk, skin breakdown from drooling, or experience social effects like emba...

How do you dose steroids in neurosarcoidosis patients with a worsening clinical symptoms or MRI findings?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Virginia Commonwealth University Health System

The route of dosing of glucocorticoids for neurosarcoidosis typically depends on the severity of illness and symptoms. For example, significant CNS involvement on imaging or patients presenting with AMS, weakness, vision changes/loss, or seizures would benefit from IV methylprednisolone followed by ...

When would you consider neuro-stimulants in post-stroke patients?

1
3 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

To my knowledge, there are no large, randomized trials supporting the use of neurostimulants in stroke rehabilitation. When patients are too sleepy to participate in therapy, I have been known to use very low-dose methylphenidate or modafinil. Levodopa has also been tried with mixed results.

What is the practical application of serological MS disease activity testing (offered by Octave Bio) for patients with MS?

2 Answers

Mednet Member
Mednet Member
Neurology · University of South Alabama

I have been using the MSDA in my clinic for about a year now. I have found it to be a reliable indicator of suspected, known, and in a few cases, impending, disease activity. When to order it and why is where I think we need to do some work. Some examples where I think it has been useful for my pati...

What was the rationale behind using RANO-HGG criteria instead of RAPNO criteria for the primary endpoint in the FIREFLY-1 trial for pLGG?

2 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · University of Toronto Faculty of Medicine

I think this was a mistake, but I understand that this was requested by the FDA. We all know that MEK and BRAF inhibitors change the pattern of enhancement within days/weeks after the beginning of the treatment. As RANO-HGG is essentially based on the assessment of enhancing measurable and nonmeasur...

In those with a history of anti-NMDA encephalitis with identified teratoma s/p resection and clinical symptom improvement, is there a role for monitoring anti-NMDA antibody titer as a marker of disease recurrence?

1 Answers

Mednet Member
Mednet Member
Neurology · University of Pennsylvania

This has been extensively answered in the literature. The paper of Gresa-Arribas et al., PMID 24360484 in Lancet Neurol 2014 answers the question. "In the current study, the importance of CSF antibody titers is demonstrated in patients with clinical relapses in whom the fluctuation of CSF titers cor...

Are CGRP antagonists effective at aborting intractable headaches in hospitalized patients when traditional “migraine cocktails” have failed?

2 Answers

Mednet Member
Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine

The time has come for us to limit ourselves in our treatment of migraine patients to migraine-specific medications. These are the triptans and gepants for abortive treatment and the CGRP antibodies and gepants for preventive treatment. The "migraine cocktails" that we employ in emergency room and ho...

Do you recommend any diagnostic testing for patients with blepharospasm?

1 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

I don't think there is a single best algorithm to work up patients with blepharospasm. I think it is important to distinguish blepharospasm from excessive eye blinking as a reaction to eye irritation or as a manifestation of behavioral or psychiatric issues. An eye exam an be helpful in this case. I...